Leave Your Message
slide1

C5

Alpha Lifetech can provide C5 corresponding products, help each customer's research and development.

CONTACT US
01

Introduction To c5 

Drug targets a biomolecule that can directly bind to drugs and then react. Generally, the target refers to a protein, which is related to the cause of disease. The focus of the target began with focusing on tumors, and then began to spread to various fields. C5 protein is a common target in medicine.
When the body is sick, our complement system can control the tumor in two aspects, one is the generation of the tumor, the continuous development of the tumor on the other. The immune monitoring of complement to the body is accomplished by controlling the damage of the immune system to tumors. At the same time, a large number of primed complements can also use other ways to strengthen the host's immune response and limit tumor growth.

Function of Target C5

C5 is the complement in the blood of the organism and is the first molecule capable of causing damage to MAC. The C5 protein is composed of α and β chains, and the domain of the C5 protein consists of 4 parts with 1669 AA. The complement system can be initiated through three different pathways, among which complement C5 is an indispensable activation product in the body complement system. In either of the three, the result is that C5 has ruptured. C5 lyase cleaves C5 into C5a and C5b, both of which have different roles.
After C5a binds and then activates C5aR, it will cause various effects in the body, such as activating cells and expressing inflammatory factors, and C5a also plays an important role in asthma and inflammatory diseases. Moreover, C5aR1 and C5aR1 also play major roles in Alzheimer's disease and cancer.
The C5b-9 protein in MAC is the final product after the complement system is initiated, C5b-9 protein is formed by multiple proteins, such as C5b with C6, C9, C7, C8, and multiple C 9, and C5b-9 protein appears on the surface of the cell membrane. The final formation of C5b-9 can create the cell membrane pore, by placing itself between the bilayer gaps of the membrane. This causes the body membrane to appear broken, the cells appear dissolved, causing damage to the body. At the same time, C5b-9 is also affected by CD59. If CD59 binds, the production of C5b-9 will be affected, thus protecting the body cells from being broken by C5b-9. In addition, C5b-9 can cause cell death in other ways, causing the body to respond.
C5
Fig 1: Structure/function of C5. (Reference documentation: Rawal N, Pangburn MK. Structure/function of C5 convertases of complement. Int Immunopharmacol. 2001 Mar;1(3):415-22. )

Alpha Lifetech Can Provide

At present, various drugs targeting C5 are constantly under development, and taking drugs alone or together with other products to treat diseases has become a new method and remarkable achievements have been made. C5 protein has shown important research value and application prospects in tumor biology, and drug research and development. With further research and technological advances, C5 protein products are also essential. Alpha Lifetech can provide C5 corresponding products and help each customer's research and development. In addition, Alpha Lifetech can provide efficient and accurate EC50 / IC50, helping customer companies to screen compounds efficiently and accurately. At the same time, Alpha Lifetech also provides some services such as recombinant antibody production and recombinant antibody purification, to conduct in vitro affinity screening to ensure the maturity of recombinant antibody affinity and help customers in antibody drug discovery, and subsequent various experiments.
Catalog Number Product Name Product Sizes
ADT1153 100ug,1mg,5mg
ADT1192 100ug,1mg,5mg
ADT1348
ADT1348-Lendalizumab Biosimilar-Anti-C5 mAb – Research Grade
100ug,1mg,5mg
ADT1459
ADT1459-Olendalizumab Biosimilar– Anti-C5 mAb – Research Grade
1mg,5mg
ADT1503
ADT1503-Pexelizumab Biosimilar– Anti-C5 mAb – Research Grade
1mg,5mg
ADT1517
ADT1517-Pozelimab Biosimilar– Anti-C5 mAb – Research Grade
100ug,1mg,5mg
ADT1537
ADT1537-Ravulizumab Biosimilar– Anti-C5 mAb – Research Grade
1mg,5mg
ADT1643
ADT1643-Tesidolumab Biosimilar– Anti-C5 mAb – Research Grade
100ug,1mg,5mg
ADT1700
ADT1700-Vilobelimab Biosimilar-Anti-C5 mAb – Research Grade
100ug,1mg,5mg

Reference 

[1] Inoue K. C5 neoepitopes appearing during activation. Complement Inflamm. 1989;6(3):219-22.. 
[2] Woodruff TM, Nandakumar KS, Tedesco F. Inhibiting the C5-C5a receptor axis. Mol Immunol. 2011 Aug;48(14):1631-42 
[3] Rawal N, Pangburn MK. Structure/function of C5 convertases of complement. Int Immunopharmacol. 2001 Mar;1(3):415-22..

Video Resources


If you have any questions, please feel free to contact us at any time.

Leave Your Message

Featured Service